22 February 2022 - South Korean pharmaceutical giant Celltrion said Tuesday that a high concentration version of its auto-immune disease ...
15 February 2022 - A court dismissed local drug makers’ appeal to nullify the Government’s push to negotiate the recollection ...
9 February 2022 - Pharmaceutical industry officials are paying attention to how the Korean government will manage health insurance benefits ...
28 January 2022 - The government granted health insurance benefits for Bausch Health Korea’s glaucoma treatment Vyzulta (latanoprostene bunod) and ...
17 January 2022 - The government’s recognition of MSD’s Keytruda (pembrolizumab) for reimbursement as the first-line therapy for lung cancer ...
14 January 2022 - Novartis’ breakthrough cancer treatment Kymriah (ingredient: tisagenlecleucel), which costs over 500 million won (US$421,000), has become ...
25 November 2021 - AstraZeneca Korea’s non-small-cell lung cancer treatment Tagrisso (osimertinib) and Ono Pharma Korea’s immunotherapy Opdivo (nivolumab) failed ...
10 November 2021 - Korea Research-based Pharma Industry Association (KRPIA) expressed concerns over HIRA's plan of evaluating a drug’s cost ...
14 October 2021 - The world’s first CAR-T therapy, Kymriah (tisagenlecleucel), passed the review of a panel at the Health ...
1 October 2021 - Takeda Korea said its ovarian cancer treatment Zejula would receive expanded health insurance coverage as maintenance ...
28 September 2021 - This study, which was conducted as part of a project for revision of the pharmacoeconomic ...
27 September 2021 - Avastin (bevacizumab), a vascular endothelial growth factor (VEGF) inhibitor, is almost a staple in anticancer treatment ...
17 September 2021 - This study aimed to evaluate manufacturers’ perceptions of the decision-making process for new drug reimbursement and to ...
9 September 2021 - Pfizer’s Vyndamax (tafamidis), a treatment for transthyretin amyloid cardiomyopathy, got in the European Society of Cardiology’s ...
7 September 2021 - The first and only targeted therapy to treat hormone receptor positive and human epidermal growth factor ...